Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway

Fig. 1

LINC00893 is downregulated in PCa tissues and cell lines. A, B LINC00893 expression levels in PCa tissues and paired para-cancerous tissues were compared in TCGA database (A), and in GSE73397 & GSE26910 datasets from GEO database (B). C The relative LINC00893 expression level was examined in 66 pairs of PCa tissues and para-cancerous tissues by RT-qPCR. D LINC00893 expression levels were examined in PCa cell lines (PC-3, DU145, VCaP and LNCaP) and human normal prostate epithelial cell line (RWPE-1) by RT-qPCR. E 66 PCa patients were divided into LINC00893low (n = 33) and LINC00893high (n = 33) group according to the median value of LINC00893 expression. Kaplan–Meier survival analysis was used to evaluate the overall survival rate of patients in the two groups. Three independent assays were performed with three technical replicates in C and D. The error bars are defined as s.d. *, P < 0.05, **, P < 0.01, and ***, P < 0.001

Back to article page